We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBSN
651
DELISTED
WEBSENSE INC
WBSN
$11.9M 0.03%
+479,016
New +$9.57M
OZK icon
652
Bank OZK
OZK
$5.69B
$11.9M 0.03%
+547,174
New +$11.7M
AEPI
653
DELISTED
AEP Industries Inc
AEPI
$11.8M 0.03%
+158,800
New +$12M
AAN.A
654
DELISTED
The Aaron's Company Inc Class A
AAN.A
$11.8M 0.03%
+420,324
New +$11.8M
GWW icon
655
W.W. Grainger
GWW
$61.5B
$11.7M 0.03%
+46,500
New +$11.5M
ESC
656
DELISTED
EMERITUS CORP
ESC
$11.7M 0.03%
+504,900
New +$12.8M
TEVA icon
657
Teva Pharmaceuticals
TEVA
$42.8B
$11.7M 0.03%
+298,363
New +$11.6M
ASCA
658
DELISTED
AMERISTAR CASINOS INC
ASCA
$11.7M 0.03%
+443,700
New +$11.7M
TNH
659
DELISTED
Terra Nitrogen
TNH
$11.6M 0.03%
+54,300
New +$11.3M
KS
660
DELISTED
KapStone Paper and Pack Corp.
KS
$11.6M 0.03%
+576,400
New +$8.86M
BIO icon
661
Bio-Rad Laboratories Class A
BIO
$9.68B
$11.6M 0.03%
+103,200
New +$12.1M
BMR
662
DELISTED
BIOMED REALTY TRUST INC
BMR
$11.6M 0.03%
+571,100
New +$12.4M
ISIL
663
DELISTED
Intersil Corp
ISIL
$11.4M 0.03%
+1,466,738
New +$11.5M
SAP icon
664
SAP
SAP
$236B
$11.4M 0.03%
+156,800
New +$12.2M
CAB
665
DELISTED
Cabela's Inc
CAB
$11.4M 0.03%
+175,600
New +$11.4M
GPOR
666
DELISTED
Gulfport Energy Corp.
GPOR
$11.3M 0.03%
+239,900
New +$11.8M
ARUN
667
DELISTED
ARUBA NETWORKS, INC.
ARUN
$11.3M 0.03%
+733,900
New +$13.3M
IDCC icon
668
InterDigital
IDCC
$9.07B
$11.3M 0.03%
+252,293
New +$11.3M
CIGI icon
669
Colliers International
CIGI
$5.15B
$11.3M 0.03%
+614,898
New +$11.6M
PBA icon
670
Pembina Pipeline
PBA
$28.4B
$11.2M 0.03%
+366,994
New +$11.7M
SKS
671
DELISTED
SAKS INCORPORATED
SKS
$11.2M 0.03%
+822,862
New +$10.6M
SMFG icon
672
Sumitomo Mitsui Financial
SMFG
$166B
$11.2M 0.03%
+1,216,400
New +$10.9M
CVA
673
DELISTED
Covanta Holding Corporation
CVA
$11.2M 0.03%
+558,316
New +$11.2M
RWT
674
Redwood Trust
RWT
$592M
$11.2M 0.03%
+656,300
New +$13.5M
HTH icon
675
Hilltop Holdings
HTH
$2.25B
$11.1M 0.03%
+679,337
New +$10.1M

Similar funds

Jim Simons's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.